Primary localized amyloidoma of the renal pelvis: A case report and literature review
- Authors:
- Published online on: December 16, 2015 https://doi.org/10.3892/ol.2015.4038
- Pages: 1095-1100
Abstract
Introduction
Localized amyloidoma is generally divided into two styles: AL-type and AA-type. AL-type occurs with an immunocyte dyscrasia while AA-type occurs with chronic infection, non-immunocyte neoplasia or inflammation. Localized amyloidoma occurs most often in the mediastinum or abdomen. Although amyloidomas may occur in almost all organ systems in the body; however, primary amyloidoma of the renal pelvis is rare. Using the keywords: ‘renal pelvis’, ‘amyloidoma’ and ‘amyloid tumor’ and search terms (renal pelvis) and (amyloidoma or amyloid tumor) in PubMed (National Center for Biotechnology Information, U.S. National Library of Medicine, Bethesda, MD, USA), a literature search was performed and only 26 cases of primary amyloidomas of the renal pelvis were identified (Table I) (1–23). Primary localized amyloidoma may present as hematuria and lumbago (14). A primary localized amyloidoma of the renal pelvis consists of amyloid deposits that may present as malignant tumors (15). The present study reports the rare case of a patient with amyloidoma that was confined to the renal pelvis, and the patient exhibited similar symptoms to those of upper urinary tract transitional cell carcinoma (TCC). In addition, 26 cases of patients with primary amyloidoma of the renal pelvis identified from the literature were also reviewed. Nephrectomy was the most selected treatment in the reported cases. The majority of patients achieved long time disease free survival and good prognosis. (7). The clinical and pathological features of the cases were discussed, in particular, the treatment methods and prognosis.
Case report
A 56-year-old man presented to the Department of Urology, Sun-Yat Sen University Cancer Center (Guangzhou, China) with left flank pain, symptoms of urinary irritation and intermittent gross hematuria. The patient had experienced the symptoms for 6 years; however, in the month prior to presentation, the symptoms had become worse. Ultrasonography revealed a mass with a low-intensity heterogeneous pattern that measured 55×19 mm in size and obstructed the lumen of the renal pelvis. Dilatation of the renal pelvis was located in the left kidney (Fig. 1). A preliminary diagnosis of TCC of the renal pelvis was suggested based on sonography, and therefore, a nephroureterectomy was advised. However, 5 urinary cytology tests were negative and pre-operative examinations revealed no abnormal signs, such as abdominal tenderness or rebound pain, during physical examination. Blood tests yielded the following results: Urine protein, 2+; urine red blood cell count, >3 cells/high power field; urine erythrocytes, 932 µl/l; left renal glomerular fitration rate, 18 ml/min; right renal glomerular fitration rate, 64ml/min; and the serum creatinine levels, eosinophil numbers and basophil numbers were within the normal ranges. The patient had been a smoker for ~20 years and had suffered from nephrolithiasis for 6 years. The patient possessed no known drug allergies. Subsequently, the patient agreed to undergo a nephroureterectomy.
Following surgery, the excised mass underwent additional tests. Macroscopically, the surgical specimen revealed tumors located in the renal pelvis. No clear difference in the ureter was observed. A cut section of the tumor revealed a red-yellow surface with firm regions. Microscopically, histopathological studies revealed that the tumor consisted of massive diffuse deposits of amyloid and microscopic, eosinophilic, amorphous material (Fig. 2) and an absence of neoplastic cells. The tumor stained positive for Congo red (Fig. 3), which indicates the presence of material that is retained following potassium permanganate digestion. A final diagnosis of amyloid light chain-type amyloidoma of the renal pelvis was determined. The patient received regular surveillance and was alive with no evidence of disease 5 months later.
Written informed consent was obtained from the patient for the publication of the present study.
Discussion
Amyloidosis refers to a large heterogeneous group of diseases that is characterized by extracellular deposits of amyloid in individual organs or tissue. Amyloid is an amorphous, insoluble and proteinaceous material (17). Extracellular amyloidosis consists of specific protein fibrils (24). Amyloidosis can be classified into 4 groups, consisting of primary, secondary, heredofamilial and β2-microglobulin-associated amyloidosis. This disease may be additionally classified as localized amyloidosis, which involves a single organ, or systemic amyloidosis, which involves multiple organs and is the most common classification among reported cases (6). By contrast, localized amyloidosis occurs much less frequently. (15) Systemic amyloidosis may be primary, progressive and fatal. Primary amyloidosis is commonly associated with an underlying immune dyscrasia, such as multiple myeloma and Waldenstrom's macroglobulinemia (15).
The etiology of primary localized urinary amyloidosis remains unknown; however, it may be possible that amyloid deposits are produced locally, or the submucosa of the genitourinary tract may be targeted by light-chains that are produced elsewhere. Numerous studies support the first hypothesis, as there is an absence of a monoclonal plasma component. An additional hypothesis is that protein deposits in bladder non-amyloid associated (AA) localized amyloidosis consist of the immunoglobulin λ light-chain subgroup I or IV (17).
Furthermore, non-AA localized amyloidosis has been described in the lung (25), nervous system (26), skin (24), larynx (27), intestinal tract (28) and genitourinary tract (17). Using PubMed, a literature search was performed and only 26 cases of primary amyloidomas of the renal pelvis were identified. The inclusion and exclusion criteria is whether primary localized amyloidoma. The majority of reported cases concerned with localized urinary tract amyloidosis are characterized as primary type, but secondary localized amyloidosis has been reported without a chronic systemic inflammatory state. Renal pelvis primary localized amyloidoma is an extremely rare condition, and is notable due to its clinical presentation and radiographic appearance, which mimics that of transitional cell carcinoma. In a review of the English and French literature by Monge et al (17), 169 cases of genitourinary tract localized amyloidoma were reported over the past 100 years. The renal pelvis was the most rare location identified, accounting for ~6% of the 169 cases, which was lower than the number located in the bladder, ureter and urethra. To the best of our knowledge, only 26 cases of renal pelvis primary localized amyloidoma have been reported (1–23).
Positive staining for Congo red is used to diagnose primary localized amyloidoma. In order to exclude AA-type amyloidosis, screening by pre-exposure of tissue slides to KMnO4 stain is performed, since false-negative results may be obtained using immunohistochemistry (negative for Congo red) (17). Clinical symptoms of primary localized amyloidoma of the renal pelvis typically present as gross hematuria, flank pain and urinary irritative symptoms, which mimic the symptoms of inflammation and neoplasm (21). It is challenging to distinguish between amyloidoma and upper urinary tract TCC solely from radiological findings, which may be non-specific (17). In addition, urine cytology does little to contribute to the diagnosis, since the majority of amyloid deposits are subepithelial. Consequently, to avoid misdiagnosis, upper urinary tract tumors should be evaluated microscopically by ureteroscopic biopsy when multiple urine cytology analyses are negative, or if possible, by surgical biopsy using frozen tissue sections examined prior to radical resection.
Primary localized amyloidoma possesses a relatively good prognosis in the genitourinary tract and other organ systems. Recurrence and implantation of the tumor has not been identified in reported cases. Nephrectomy was the chosen treatment in the present study, and is used in the majority of reported cases. However, by monitoring the progression of the primary localized amyloid tumor in the renal pelvis, using active surveillance with serial imageological examination, a similar outcome to nephrectomy may be observed (15). This should be considered by all urologists.
Primary localized amyloidoma is extremely rare in the renal pelvis (14,15). Consequently, there is a lack of standardized clinical symptoms and specific laboratory tests, and in addition, imageological examination mimics TCC. A pre-operative ureteroscopic biopsy or surgical biopsy is required when multiple urinary cytology analyses are not positive or a benign tumor, including primary localized amyloidoma, is suspected, to avoid an unnecessary nephroureterectomy. Early radical surgery is not required unless there is no renal function or a severe urinary tract obstruction. Instead, active surveillance with serial imageological examination may be used to monitor the progression of the lesion. In conclusion, primary localized amyloidoma of renal pelvis is a benign and rare tumor, which has a relatively good prognosis.
References
Gilbert LW and McDonald JR: Primary amyloidosis of the renal pelvis and ureter: Report of case. J Urol. 68:137–139. 1952.PubMed/NCBI | |
Chisholm GD, Cooter NB and Dawson JM: Primary amyloidosis of the renal pelvis. BMJ. 1:736–738. 1967. View Article : Google Scholar : PubMed/NCBI | |
Gardner KD Jr, Castellino RA, Kempson R, Young BW and Stamey TA: Primary amyloidosis of the renal pelvis. N Engl J Med. 284:1196–1198. 1971. View Article : Google Scholar : PubMed/NCBI | |
Ullmann AS: Primary amyloidosis of the renal pelvis: A case report and review of literature. Mich Med. 72:29–33. 1973.PubMed/NCBI | |
Dias R, Fernandes M and Patel RC: deS hadarevian JJ and Lavengood RW: Amyloidosis of renal pelvis and urinary bladder. Urology. 14:401–404. 1979. View Article : Google Scholar : PubMed/NCBI | |
Gelbard M and Johnson S: Primary amyloidosis of renal pelvis and renal cortical adenoma. Urology. 15:614–617. 1980. View Article : Google Scholar : PubMed/NCBI | |
Fujihara S and Glenner GG: Primary localized amyloidosis of the genitourinary tract: Immunohistochemical study on eleven cases. Lab Invest. 44:55–60. 1981.PubMed/NCBI | |
Fox M, Hammond JC, Knox R and Underwood JC: Localised primary amyloidosis of the renal pelvis. Br J Urol. 56:223–224. 1984. View Article : Google Scholar : PubMed/NCBI | |
Murphy MN, Alguacil-Garcia A and MacDonald RG: Primary amyloidosis of renal pelvis with duplicate collecting system. Urology. 27:470–473. 1986. View Article : Google Scholar : PubMed/NCBI | |
Davis PS, Babaria A, March DE and Goldberg RD: Primary amyloidosis of the ureter and renal pelvis. Urol Radiol. 9:158–160. 1987. View Article : Google Scholar : PubMed/NCBI | |
Sparwasser C, Gilbert P, Mohr W and Linke RP: Unilateral extended amyloidosis of the renal pelvis and ureter, A case report. Urol Int. 46:208–210. 1991. View Article : Google Scholar : PubMed/NCBI | |
Shiramizu M, Nakamura K, Baba S, Katsuoka Y and Kinoshita H: Primary localized amyloidosis of the renal pelvis coexisting with transitional cell carcinoma, A case report. Hinyokika Kiyo. 38:699–702. 1992.PubMed/NCBI | |
German KA and Morgan RJ: Primary amyloidosis of the renal pelvis and upper ureter. Br J Urol. 73:99–100. 1994. View Article : Google Scholar : PubMed/NCBI | |
Merrimen JL, Alkhudair WK and Gupta R: Localized amyloidosis of the urinary tract, Case series of nine patients. Urology. 67:904–909. 2006. View Article : Google Scholar : PubMed/NCBI | |
Borza T, Shah RB, Faerber GJ and Wolf JS Jr: Localized amyloidosis of the upper urinary, tract. A case series of three patients managed with reconstructive surgery or surveillance. J Endourol. 24:641–644. 2010. View Article : Google Scholar : PubMed/NCBI | |
Pan DL and Na YQ: Amyloidosis of the unilateral renal pelvis ureter and urinary bladder: A case report. Chin Med Sci J. 26:197–200. 2011. View Article : Google Scholar : PubMed/NCBI | |
Monge M, Chauveau D, Cordonnier C, Noël LH, Presne C, Makdassi R, Jauréguy M, Lecaque C, Renou M, Grünfeld JP, et al: Localized amyloidosis of the genitourinary tract: Report of 5 new cases and review of the literature. Medicine (Baltimore). 90:212–222. 2011. View Article : Google Scholar : PubMed/NCBI | |
Grigor T and Munro N: Amyloidosis of the renal pelvis: A harbinger of mammary carcinoma? BMJ Case Rep. 16:20152015. | |
Tsuji Y, Michinaga S and Ariyoshi A: Ileal ureter, Another option for the treatment of localized amyloidosis of the upper urinary tract. J Urol. 151:999–1000. 1994.PubMed/NCBI | |
Paidy S, Unold D and Catanzano TM: AIRP best cases in radiologic-pathologic correlation, localized amyloidosis of the renal pelvis. Histopathology. Inc. 32:2025–2030. 2012. | |
Zhou F, Lee P, Zhou M, Melamed J and Deng FM: Primary localized amyloidosis of the urinary tract frequently mimics neoplasia, A clinicopathologic analysis of 11 cases. Am J Clin Exp Urol. 2:71–75. 2014.PubMed/NCBI | |
Akimoto K: Ober amyloidartigeE iweissniederschlage im Nierenbecken. Beitr Pathol Anat. 78:2391927. | |
Sato S: Primary amyloidosis of the renal pelvis and ureter: R eport of a case. Acta Med Biol. 5:151957. | |
Reitboeck JG, Feldmann R, Loader D, Breier F and Steiner A: Primary cutaneous amyloidoma, A case report. Case Rep Dermatol. 6:264–267. 2014. View Article : Google Scholar : PubMed/NCBI | |
Dong MJ, Zhao K, Liu ZF, Wang GL and Yang J: Primary pulmonary amyloidosis misdiagnosed as malignancy on dual-time-point fluoro-deoxyglucose positron emission tomography/computed tomography, A case report and review of the literature. Oncol Lett. 9:591–594. 2015.PubMed/NCBI | |
Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust WJ, Shaw L, et al: Alzheimer's Disease Neuroimaging Initiative: Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology. 84:729–737. 2015. View Article : Google Scholar : PubMed/NCBI | |
Cheng KJ, Wang SQ and Lin S: Localized amyloidosis concurrently involving the nasopharynx, larynx and nasal cavities, A case report. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 44:875–876. 2009.(In Chinese). PubMed/NCBI | |
Yaita H, Nakamura S, Kurahara K, Nagasue T, Kochi S, Oshiro Y, Ohshima K, Ikeda Y and Fuchigami T: Primary small-bowel adult T-cell leukemia/lymphoma with gastric AL amyloidosis. Endoscopy. 46:E613–614. 2014. |